Since the beginning of the 1980s, a relatively high incidence of abnormal serum PRL levels has been reported in women with cervical carcinomas, and the use of dopamine agonists as adjunctive treatment for cervical cancer has been hypothesized. Here, PRL is linked to cervical cancer.